Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.00 | 47.43 |
| PEG Ratio (TTM) | -0.22 | -0.37 |
| P/S Ratio (TTM) | 6.21 | 6.17 |
| P/B Ratio (TTM) | 0.52 | 6.03 |
| P/FCF Ratio (TTM) | -1.52 | 41.68 |
| Price to 5YR AVG Earnings Ratio | 7.43 | 58.57 |
| Price to 5YR AVG FCF Ratio | 4.55 | 34.18 |
Profitability (10%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -46.55% | 5.30% |
| ROE (TTM) | -44.69% | 28.25% |
| Net Profit Margin (TTM) | -584.65% | 8.25% |
| ROIC 5YR AVG | 9.20% | 6.60% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -11.53% | 183.18% | 49.49% |
| Revenue | 264.43% | 11,683.28% | 6,977.54% |
| Net Income | -14.37% | 263.15% | 100.49% |
| Cash Flow | -9.51% | 206.74% | 20.01% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 9.09 | 2.90 |
| Quick Ratio (TTM) | 8.81 | 2.17 |
| D/E Ratio (TTM) | 0.04 | 0.61 |
| Interest Coverage (TTM) | -12.21 | 22.17 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | 2.06 | 7.62 |
| LTL to 5YR AVG FCF | 0.25 | 3.53 |
| Shares Outstanding Growth 5YR AVG | 20.80% | 1.60% |